top of page
LIVE:
FINANCE - LATEST
MINING - LATEST
FEATURED
SUBSCRIBE TO OUR NEWSLETTER
MINING
Coal Waste Emerges as Strategic Asset in New $7.5 Million U.S. Initiative
The U.S. Department of Energy is backing new projects to recover critical minerals from coal waste, turning an old industrial byproduct into a potential new supply chain opportunity.
DoD’s $250M Fluorspar Contract Proves Domestic Push Was Inevitable, ARES Sole Player
Don’t say we didn’t tell you so. Endeavor picked this hot tips months ago and if you have bought, you’re welcome – we love this company and are confident there’s plenty more room for growth.
Ares Strategic Mining Wins $169M Pentagon Contract
Ares Strategic Mining has secured a landmark $169M multi-year Pentagon contract (up to $250M), a momentous move by the U.S. to secure and stockpile a domestic fluorspar supply. If the buzz around Ares sounds familiar, it should – We’ve been flagging this company as a worthy endeavor for some time.
Critical Minerals Market Prediction for 2026
As the race to secure energy transition inputs accelerates, BMI expects 2026 to be defined less by explosive price moves and more by strategic positioning. Here’s what investors can expect across mining sectors in 2026.
Copper and Silver Added to U.S. Critical Minerals List
The U.S. Geological Survey (USGS) has officially designated copper and silver as critical minerals, marking a major shift in how policymakers view metals essential to both industrial innovation and national defense.
MOST POPULAR
FINANCE
U.S. Oil Giants Poised for Profit Surge as Fuel Prices Draw Political Pressure
U.S. oil companies are expected to post sharply higher profits as stronger crude prices and summer fuel demand boost the energy sector, even as rising gasoline prices begin attracting renewed political pressure in Washington.
Crypto Is Quietly Rebuilding Its Banking System
Regional banks are emerging as potential new players in the crypto industry as digital assets move closer to the financial mainstream. The shift could create fresh growth opportunities for smaller lenders looking to expand beyond traditional banking services.
INVESTING
What are Pink Sheets?
Do they still exist? What is their place in the current market?
Firmus’ AI Data Center Marks Another Win for NVIDIA
Indonesia is making a major push into artificial intelligence, with AI startup Firmus Technologies partnering with NVIDIA to build a new AI-focused data center. While the project is based in Southeast Asia, it underscores a much larger trend for investors: global demand for AI infrastructure is accelerating, creating new opportunities for NVIDIA and the broader AI supply chain.
Why BT and Verizon’s $4 Billion Partnership Matters for Investors
BT and Verizon’s $4 billion joint venture is more than a business partnership it’s a strategic bet on the future of enterprise networking. Here’s what the deal means for investors, why the market reacted positively, and the broader trend reshaping the telecommunications industry. When two telecom giants decide to join forces, investors should pay attention. […]
Uranium Market Enters 2026 With Momentum
Nuclear expansion goals in the US are gaining traction just as supply tightens worldwide, adding weight to uranium’s renewed rally.
Project Vault: What 60 Days of U.S. Battery Minerals Could Cost in 2026
A 60-day mineral buffer sounds simple. The price tag, and the geopolitical implications, are not.
PHARMACEUTICAL
Cancer treatment could identify patients most likely to respond to cancer drugs
Scientists from the Cancer Research UK Scotland Institute and Memorial Sloan Kettering Cancer Centre have discovered a cancer treatment that can identify patients who are more likely to respond to cancer drugs. Funded by Cancer Research UK and published in Nature Cancer, the study reveals new ways to identify patients who could benefit most from […]
Trump’s Drug Pricing Push Could Put Smaller Pharma Firms Under Pressure
Pressure is building across the healthcare sector as renewed calls for lower U.S. drug prices raise concerns for smaller pharmaceutical companies and biotech investors.
Renalytix Surges 24% as Long-Term Data Strengthens the Investment Story
Renalytix shares surged 24% after new two-year clinical data reinforced the effectiveness of its AI-powered KidneyIntelX test. More importantly for investors, the results strengthen the company’s commercial case, shifting the focus from proving the science to proving the business.
Generative AI’s First Real-World Health Test
A new university-led study puts generative AI head-to-head with traditional research teams in a high-stakes medical data challenge, with surprising results.
UK-US Zero Tariff Deal on Pharmaceuticals
The US and UK have reached a zero-tariff deal on pharmaceuticals, but the real impact can be felt across investment, innovation, and public health.
TECHNOLOGY
AI Bubble Fears Ease as Markets Hold Steady, Says BIS
AI bubble concerns appear to be easing in market behaviour, according to the BIS, despite elevated AI-linked valuations. The report notes a lack of typical bubble stress signals, with continued inflows into AI stocks and limited risk-off positioning. It also highlights AI being increasingly treated as a structural growth theme, alongside ongoing debate around valuations and market concentration.
Ever heard of the ‘SaaSpocalypse’? Software plunge explained
Software stocks are facing their steepest reckoning in years as AI upends long-held assumptions about growth, pricing power, and competitive moats.
AI Investment Set to Keep Rising, OECD Says
Rising investment in artificial intelligence continues to underpin global growth, according to the OECD. While economic momentum is expected to cool in 2026, policymakers are seeing the upside.
Analysts Call Broadcom a Top AI Stock to Watch
Broadcom just earned “Top Pick” status from Jefferies, as analysts say the chipmaker is hitting an AI inflection point. With booming demand and a growing software base, Broadcom’s next phase could be its biggest yet.
Why the AI Rally Might Be Too Hot to Handle
The latest surge in AI-linked stocks is dazzling investors but raising a the question: have markets learned anything from 1999?
bottom of page